Home/Filings/4/0001104659-20-090283
4//SEC Filing

Lavino Francesco Maria 4

Accession 0001104659-20-090283

CIK 0001641640other

Filed

Aug 3, 8:00 PM ET

Accepted

Aug 4, 4:09 PM ET

Size

4.5 KB

Accession

0001104659-20-090283

Insider Transaction Report

Form 4
Period: 2020-07-31
Lavino Francesco Maria
Chief Commercial Officer
Transactions
  • Tax Payment

    Ordinary Shares

    2020-07-31$0.76/sh366$278178,634 total

Documents

1 file

Issuer

Nabriva Therapeutics plc

CIK 0001641640

Entity typeother

Related Parties

1
  • filerCIK 0001711517

Filing Metadata

Form type
4
Filed
Aug 3, 8:00 PM ET
Accepted
Aug 4, 4:09 PM ET
Size
4.5 KB